Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 06:51 am Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
KDev Investments AB | 89,035 8.400% |
-33,207 (-27.17%) |
Filing History |
| 2021-02-12 4:17 pm Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
SECTORAL ASSET MANAGEMENT INC | 8,184 0.770% |
-65,333 (-88.87%) |
Filing History |
| 2021-02-11 2:23 pm Sale |
2020-12-31 | 13G | Aprea Therapeutics, Inc. APRE |
JANUS HENDERSON GROUP PLC JHG |
0 0.000% |
-90,543 (Position Closed) |
Filing History |
| 2021-02-10 09:23 am Sale |
2021-02-09 | 13G | Aprea Therapeutics, Inc. APRE |
FMR LLC | 1 0.000% |
-63,063 (-100.00%) |
Filing History |
| 2021-02-08 10:15 am Sale |
2021-02-05 | 13G | Aprea Therapeutics, Inc. APRE |
FMR LLC | 63,064 5.953% |
-44,057 (-41.13%) |
Filing History |
| 2020-11-19 4:27 pm Sale |
2020-11-16 | 13D | Aprea Therapeutics, Inc. APRE |
5AM Ventures IV L.P. | 68,883 6.500% |
-33,000 (-32.39%) |
Filing History |
| 2020-10-07 5:00 pm Sale |
2020-10-05 | 13D | Aprea Therapeutics, Inc. APRE |
5AM Ventures IV L.P. | 101,883 9.600% |
-15,750 (-13.39%) |
Filing History |